Skip to content

Evaluation of coagulation abnormalities in brain tumors in the perioperative period

Evaluation of coagulation profile in supratentorial primary brain tumors in the perioperative period using Thromboelastography

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/01/011272
Enrollment
25
Registered
2018-01-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Supratentorial primary brain tumors, undergoing surgery for removal of tumor

Interventions

None listed

Sponsors

Dr Manikandan S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Surgery for newly diagnosed primary brain tumors in supratentorial area with tumor size >3 cm ASA 1,2 GCS 14-15 Exclusion criteria: Ã? GCS

Exclusion criteria

Exclusion criteria: GCS ASA 3&4 Recurrent tumors. Presence of significant co morbidities like diabetes, hypertension, liver disease, ischemic heart disease, stroke, chronic renal disease etc which are known to affect the coagulation system. Patients on chronic anti platelet or anticoagulant therapy. Patients on OCPs. Patients with other hematological disorders. Also excluded will be patients who have had massive blood loss and transfusion, prolonged preoperative immobility, patients requiring mechanical ventilation and prolonged immobilization post operatively. Post operative re exploration.

Design outcomes

Primary

MeasureTime frame
To study the temporal trends in Coagulation profile over time in the perioperative period in patients with Supratentorial Primary Brain tumors using TEGTimepoint: Pre operatively, 24 hours, 48 hours, 72 hours post operaively

Secondary

MeasureTime frame
To identify the presence of any specific patterns of Coagulation abnormality in patients with Supratentorial Brain tumors in the perioperative period.Timepoint: Pre operatively, 24 hours, 48 hours, 72 hours post operaively

Countries

India

Contacts

Public ContactDr Manikandan S

Sree Chitra Tirunal Institute for Medical Sciences and Technology

kanmanisethu@gmail.com9446334711

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026